#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15450	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2121	724.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	911	C	835	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15450	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2121	724.4	0	HET	.	.	.	A69G,T	.	69	69	A	300	300	A	869	A,G,T	606,186,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28632	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3467	822.7	0	.	n	.	0	T695C	SNP	695	695	T	994	994	C	930	C	851	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28632	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3467	822.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1636	1636	A	988	A	913	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28632	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3467	822.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2270	2270	C	919	C,G	837,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28632	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3467	822.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2344	2344	A	899	A	825	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28632	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3467	822.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2896	2896	C	879	C	827	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2136	folP	855	855	100.0	folP.l15.c17.ctg.1	1428	148.6	1	SNP	p	R229S	1	.	.	685	687	AGC	968	970	AGC	216;215;218	A;G;C	201;202;202	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5436	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3348	162.0	1	SNP	p	S91F	1	.	.	271	273	TTC	556	558	TTC	192;189;188	T;T;C	180;175;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5436	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3348	162.0	1	SNP	p	G95N	0	.	.	283	285	GGC	568	570	GGC	189;189;189	G;G;C	175;176;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5436	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3348	162.0	1	SNP	p	D95G	1	.	.	283	285	GGC	568	570	GGC	189;189;189	G;G;C	175;176;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1792	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1530	116.8	1	SNP	p	G45D	0	.	.	133	135	GGC	554	556	GGC	214;211;210	G;G;C	200;201;194	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	910	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	936	95.8	0	.	n	.	0	A197.	DEL	197	197	A	517	517	A	229	A	213	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	178.0	1	SNP	p	D86N	0	.	.	256	258	GAC	546	548	GAC	191;188;188	G;A;C	176;171;176	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	178.0	1	SNP	p	R87I	0	.	.	259	261	CGT	549	551	CGT	187;184;185	C;G;T	175;171;170	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	178.0	1	SNP	p	S87R	1	.	.	259	261	CGT	549	551	CGT	187;184;185	C;G;T	175;171;170	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	178.0	1	SNP	p	R87W	0	.	.	259	261	CGT	549	551	CGT	187;184;185	C;G;T	175;171;170	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2891	178.0	1	SNP	p	S88P	0	.	.	262	264	TCC	552	554	TCC	186;187;185	T;C,G;C	173;172,1;172	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4574	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2474	183.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1462	1464	GGC	237;236;235	G;G;C	218;216;212	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1155	1157	GCA	230;233;233	G;C;A	209;213;214	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1158	1160	ATC	231;234;234	A;T;C,T	214;215;214,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1170	1172	GTG	239;239;238	G;T;G	217;215;215	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1170	1172	GTG	239;239;238	G;T;G	217;215;215	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1674	1676	ACC	212;215;216	A;C;C	188;199;201	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1728	1730	GCG	224;222;224	G,C;C;G	185,1;177;182	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1728	1730	GCG	224;222;224	G,C;C;G	185,1;177;182	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1851	1853	AGC	193;191;192	A;G;C	183;180;179	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1860	1862	GGC	193;193;196	G;G;C	176;175;177	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4188	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2199	188.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1878	1880	CCG	180;185;182	C,G;C;G	123,5;132;133	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5854	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3176	183.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1674	1676	CCG	218;214;218	C;C;G	187;190;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2196	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1755	124.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	495	495	C	141	C	133	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	501	503	GAA	227;223;221	G;A;A	217;211;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	K120N	NONSYN	358	360	AAG	747	749	AAC	230;227;229	A;A;C	212;209;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	789	791	GAT	230;232;235	G;A;T	210;212;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	912	914	TCA	227;231;232	T;C;A	209;212;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1041	1043	GTC	245;248;248	G;T;C,A	234;235;237,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1053	1055	TCT	242;241;241	T;C,T;T	229;228,1;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1371	1373	GCA	215;218;217	G;C;A	200;203;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	1	SNP	p	A121D	1	.	.	361	363	GAC	750	752	GAC	232;234;233	G;A;C	215;214;216	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2862	porB1b	1047	1047	99.14	porB1b.l6.c4.ctg.1	1713	166.5	1	SNP	p	D121N	0	.	.	361	363	GAC	750	752	GAC	232;234;233	G;A;C	215;214;216	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10836	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4733	228.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1164	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	993	116.5	1	SNP	p	V57M	1	.	.	169	171	ATG	533	535	ATG	249;252;251	A;T;G	229;229;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
